Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant glandular neoplasm arising from the exocrine pancreas. Microscopically it is characterized by the presence of mucoid stroma formation, papillary patterns, and cystic changes. It has been associated with KRAS and Tp53 gene mutations.
Biomarker and diagnostic research for pancreatic intraductal papillary-mucinous carcinoma has been reported in the published literature.
No clinical trials have been registered for pancreatic intraductal papillary-mucinous carcinoma.
156 publications have been identified in PubMed for pancreatic intraductal papillary-mucinous carcinoma. Kisho has analyzed 107 by research type. Research spans Review / Meta-Analysis (24%), Epidemiology / Natural History (21%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 26 | 24% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression |
22 |
21% |
Testing and diagnosis research | 17 | 16% |
Patient case studies | 16 | 15% |
Laboratory research | 13 | 12% |
Clinical study results | 9 | 8% |
Other research | 2 | 2% |
New treatment approaches | 2 | 2% |
Pollini T (2026). [PMID: 41224443](https://pubmed.ncbi.nlm.nih.gov/41224443/). *Hematol Oncol Clin North Am*. [Review / Meta-Analysis]
Tanner S (2026). [PMID: 41284225](https://pubmed.ncbi.nlm.nih.gov/41284225/). *United European Gastroenterol J*. [Review / Meta-Analysis]
Maino C (2026). [PMID: 41932105](https://pubmed.ncbi.nlm.nih.gov/41932105/). *Eur J Radiol*. [Review / Meta-Analysis]
Nardi P (2026). [PMID: 41469095](https://pubmed.ncbi.nlm.nih.gov/41469095/). *Anticancer Res*. [Review / Meta-Analysis]
Fujii H (2026). [PMID: 42116653](https://pubmed.ncbi.nlm.nih.gov/42116653/). *Pathol Int*. [Case Report / Case Series]
Camisa PR (2026). [PMID: 41122920](https://pubmed.ncbi.nlm.nih.gov/41122920/). *J Pathol*. [Review / Meta-Analysis]
Abusharar M (2026). [PMID: 41640870](https://pubmed.ncbi.nlm.nih.gov/41640870/). *World J Gastroenterol*. [Review / Meta-Analysis]
Lee G (2026). [PMID: 41320174](https://pubmed.ncbi.nlm.nih.gov/41320174/). *J Gastroenterol Hepatol*. [Epidemiology / Natural History]
Pea A (2026). [PMID: 41775703](https://pubmed.ncbi.nlm.nih.gov/41775703/). *Nat Commun*. [Basic Science / Preclinical]
Holmberg M (2026). [PMID: 41874453](https://pubmed.ncbi.nlm.nih.gov/41874453/). *United European Gastroenterol J*. [Clinical Trial Publication]